| Rachel Ann Wilkenson, MD | |
|
875 W Moreno Ave, Colorado Springs, CO 80905-1731 | |
| (719) 572-6100 | |
| Not Available |
| Full Name | Rachel Ann Wilkenson |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 23 Years |
| Location | 875 W Moreno Ave, Colorado Springs, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679785802 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Matthews-vu Medical Group, P.c. | 3072790864 | 40 |
News Archive
The pharmaceutical industry trade group PhRMA said Monday that the Food and Drug Administration should do a better job of explaining additional safeguards it mandates against certain drugs when it issues warnings, Reuters reports.
As Congress prepares to reconvene next week following an August recess period filled with wide-ranging local discussion of health care reform, the Texas kidney community expressed hope that the momentum and public desire for health care reform in Washington can help drive momentum and discussion in Texas about the vital need to open 38 end stage renal disease (ESRD) centers still sitting idle, which, if opened, will dramatically expand access to quality dialysis care and create good-paying local jobs.
New research in the Journal of Leukocyte Biology shows the link between the nervous and immune systems and how breaking that link might lead to new treatments for a wide range of autoimmune disorders
University of California San Diego School of Medicine will receive $2.6 million to expand its existing Program in Medical Education (PRIME) on healthy equity, and launch a new PRIME program focused on Native American health.
Alexion Pharmaceuticals, Inc. today announced that researchers are scheduled to present new data relating to Soliris (eculizumab) as a treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH) during the 52nd Annual Meeting of the American Society of Hematology (ASH), to be held December 4 - 7, 2010 at the Orange County Convention Center in Orlando.
› Verified 1 days ago
| Entity Name | Matthews-vu Medical Group, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649438433 PECOS PAC ID: 3072790864 Enrollment ID: O20110603000138 |
News Archive
The pharmaceutical industry trade group PhRMA said Monday that the Food and Drug Administration should do a better job of explaining additional safeguards it mandates against certain drugs when it issues warnings, Reuters reports.
As Congress prepares to reconvene next week following an August recess period filled with wide-ranging local discussion of health care reform, the Texas kidney community expressed hope that the momentum and public desire for health care reform in Washington can help drive momentum and discussion in Texas about the vital need to open 38 end stage renal disease (ESRD) centers still sitting idle, which, if opened, will dramatically expand access to quality dialysis care and create good-paying local jobs.
New research in the Journal of Leukocyte Biology shows the link between the nervous and immune systems and how breaking that link might lead to new treatments for a wide range of autoimmune disorders
University of California San Diego School of Medicine will receive $2.6 million to expand its existing Program in Medical Education (PRIME) on healthy equity, and launch a new PRIME program focused on Native American health.
Alexion Pharmaceuticals, Inc. today announced that researchers are scheduled to present new data relating to Soliris (eculizumab) as a treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH) during the 52nd Annual Meeting of the American Society of Hematology (ASH), to be held December 4 - 7, 2010 at the Orange County Convention Center in Orlando.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rachel Ann Wilkenson, MD 875 W Moreno Ave, Colorado Springs, CO 80905-1731 Ph: (719) 572-6100 | Rachel Ann Wilkenson, MD 875 W Moreno Ave, Colorado Springs, CO 80905-1731 Ph: (719) 572-6100 |
News Archive
The pharmaceutical industry trade group PhRMA said Monday that the Food and Drug Administration should do a better job of explaining additional safeguards it mandates against certain drugs when it issues warnings, Reuters reports.
As Congress prepares to reconvene next week following an August recess period filled with wide-ranging local discussion of health care reform, the Texas kidney community expressed hope that the momentum and public desire for health care reform in Washington can help drive momentum and discussion in Texas about the vital need to open 38 end stage renal disease (ESRD) centers still sitting idle, which, if opened, will dramatically expand access to quality dialysis care and create good-paying local jobs.
New research in the Journal of Leukocyte Biology shows the link between the nervous and immune systems and how breaking that link might lead to new treatments for a wide range of autoimmune disorders
University of California San Diego School of Medicine will receive $2.6 million to expand its existing Program in Medical Education (PRIME) on healthy equity, and launch a new PRIME program focused on Native American health.
Alexion Pharmaceuticals, Inc. today announced that researchers are scheduled to present new data relating to Soliris (eculizumab) as a treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH) during the 52nd Annual Meeting of the American Society of Hematology (ASH), to be held December 4 - 7, 2010 at the Orange County Convention Center in Orlando.
› Verified 1 days ago
Justin Cheongsiatmoy, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 24 S Weber St Ste 200, Colorado Springs, CO 80903 Phone: 424-652-8506 | |
William B. Scholten, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 875 W. Moreno Ave., Colorado Springs, CO 80905 Phone: 719-572-6424 | |
Kevin K. Snyder, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1115 Elkton Dr Ste 300, Colorado Springs, CO 80907 Phone: 719-373-9703 Fax: 719-631-7017 | |
Dr. Laura Jane Elder, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4215 Stonehaven Dr, Colorado Springs, CO 80906 Phone: 972-816-7870 | |
William Tyler Stone, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1715 N Weber St, Suite 120, Colorado Springs, CO 80907 Phone: 719-722-4929 Fax: 719-358-9860 | |
Dr. Abdurahman Said Elkhetali, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1400 E Boulder St Ste 700, Colorado Springs, CO 80909 Phone: 719-365-7300 Fax: 719-365-7301 | |
Roy Alan Kanter, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4110 Briargate Pkwy Ste 405, Colorado Springs, CO 80920 Phone: 719-365-7300 Fax: 719-365-7301 |